Efficacy and Safety of Coenzyme Q10 (100 mg/day) as an Adjunctive Therapy in Migraine Prophylaxis: A Randomized Controlled Open-Label Study

Authors
Category Primary study
JournalIntl. J. Curr. Pharm. Rev. Res.
Year 2025
This article has no abstract
Epistemonikos ID: a24eb2a2d59ec8033c07fa1802b069ca79f4c866
First added on: Oct 17, 2026